1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE β-LACTAMASE INHIBITORS
-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D -lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclose...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BUSCH ROBERT ALEXANDER DYLAN C YIN NING GU YU GUI METCALF CHESTER A. III HE YONG CROSS JASON B |
| description | -Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D -lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20140144254A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20140144254A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20140144254A3</originalsourceid><addsrcrecordid>eNrjZLAz1DHWMdH1j3B08XSM8vdxVXD0c1GACIZ4eMJFz23S9XF0DnH0dQx2VfD08_B08gzxDwrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx3kFGBoYmQGRiZGriaEycKgDVCSrV</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE β-LACTAMASE INHIBITORS</title><source>esp@cenet</source><creator>BUSCH ROBERT ; ALEXANDER DYLAN C ; YIN NING ; GU YU GUI ; METCALF CHESTER A. III ; HE YONG ; CROSS JASON B</creator><creatorcontrib>BUSCH ROBERT ; ALEXANDER DYLAN C ; YIN NING ; GU YU GUI ; METCALF CHESTER A. III ; HE YONG ; CROSS JASON B</creatorcontrib><description>-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D -lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.</description><language>eng ; kor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2014</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141218&DB=EPODOC&CC=KR&NR=20140144254A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141218&DB=EPODOC&CC=KR&NR=20140144254A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BUSCH ROBERT</creatorcontrib><creatorcontrib>ALEXANDER DYLAN C</creatorcontrib><creatorcontrib>YIN NING</creatorcontrib><creatorcontrib>GU YU GUI</creatorcontrib><creatorcontrib>METCALF CHESTER A. III</creatorcontrib><creatorcontrib>HE YONG</creatorcontrib><creatorcontrib>CROSS JASON B</creatorcontrib><title>1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE β-LACTAMASE INHIBITORS</title><description>-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D -lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2014</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAz1DHWMdH1j3B08XSM8vdxVXD0c1GACIZ4eMJFz23S9XF0DnH0dQx2VfD08_B08gzxDwrmYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx3kFGBoYmQGRiZGriaEycKgDVCSrV</recordid><startdate>20141218</startdate><enddate>20141218</enddate><creator>BUSCH ROBERT</creator><creator>ALEXANDER DYLAN C</creator><creator>YIN NING</creator><creator>GU YU GUI</creator><creator>METCALF CHESTER A. III</creator><creator>HE YONG</creator><creator>CROSS JASON B</creator><scope>EVB</scope></search><sort><creationdate>20141218</creationdate><title>1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE β-LACTAMASE INHIBITORS</title><author>BUSCH ROBERT ; ALEXANDER DYLAN C ; YIN NING ; GU YU GUI ; METCALF CHESTER A. III ; HE YONG ; CROSS JASON B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20140144254A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; kor</language><creationdate>2014</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BUSCH ROBERT</creatorcontrib><creatorcontrib>ALEXANDER DYLAN C</creatorcontrib><creatorcontrib>YIN NING</creatorcontrib><creatorcontrib>GU YU GUI</creatorcontrib><creatorcontrib>METCALF CHESTER A. III</creatorcontrib><creatorcontrib>HE YONG</creatorcontrib><creatorcontrib>CROSS JASON B</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BUSCH ROBERT</au><au>ALEXANDER DYLAN C</au><au>YIN NING</au><au>GU YU GUI</au><au>METCALF CHESTER A. III</au><au>HE YONG</au><au>CROSS JASON B</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE β-LACTAMASE INHIBITORS</title><date>2014-12-18</date><risdate>2014</risdate><abstract>-Lactamase inhibitor compounds (BLIs) are disclosed, including compounds that have activity against class A, class C or class D -lactamases. Methods of manufacturing the BLIs, and uses of the compounds in the preparation of pharmaceutical compositions and antibacterial applications are also disclosed.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; kor |
| recordid | cdi_epo_espacenet_KR20140144254A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 1,3,4-OXADIAZOLE AND 1,3,4-THIADIAZOLE β-LACTAMASE INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T01%3A43%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BUSCH%20ROBERT&rft.date=2014-12-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20140144254A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |